Currently, there are supply constraints for GLP-1 receptor agonists in the UK, with NHS guidance prioritising these medications for people with diabetes
Yes, Semaglutide effectively lowers LDL cholesterol, raises HDL cholesterol, and reduces triglycerides, improving overall lipid profiles
These gastrointestinal disturbances often occur during the initial weeks of treatment and may diminish with continued use
Notably, Zepbound, approved in late 2023, has shown the fastest growth, with sales projected to more than double from last year, reaching $11.3 billion
Here's what's actually covered employer plans, Medicare, Medicaid, and your options when insurance says no
Here's what you can expect: Weeks 1-2: You may feel fuller faster and that "food noise" in your head, constant cravings, may begin to disappear